Analytical and Chemical Enhancements to Improve Efficacy and Accuracy of Therapeutic Oligonucleotides
See how top pharma players are addressing impure, unstable, and off-target oligos
Boosting the Efficacy of Safe, Scalable, & Precise Vaccines
Innovations in mRNA Technology, RNA Therapeutics, and Cancer Immunotherapy for 2024
.png)
Tumbler: A Highly Customizable Antibody Optimization Suite
On-demand presentation, presented by Michali Izhaky, Bioinformatics Scientist at Charles River
Leading Innovations in Fab, ScFv, & VHH Production and Engineering
On-demand webinar presented by Dr Jiansheng Wu, Head of Protein Sciences and Vice President at WuXi Biologics
Advancing Immunotherapy: The Critical Role of GMP-Grade Cytokines in Cell Therapy
On-demand webinar presented by Ritwika Biswas, Field Application Scientist at Sino Biological
Optimizing Bispecific Antibody Production: From Identifying Optimal Pairings to Scale-up Processes
On-demand webinar presented by Dr Jiansheng Wu, Head of Protein Sciences and Vice President at WuXi Biologics
Unlocking the Future of Immune Cancer Therapy
A concise report featuring insights from the prominent though leaders of Immuno 2024.
Antibody & Protein Engineering
The Molecular Operating Environment: Biologics Design and Protein Engineering
Gene Therapy Development
Inciting Rapid Standardisation in Cell and Gene Therapy Manufacturing
Can the cell and gene therapy field create industry consensus on a more detailed level? In this Insight Article, Jorgen Magnus, Strategic Program Lead of Cell and Gene Therapy at Bayer, highlights the promise of process mapping for reaching a harmonised approach to development and manufacturing standards.
Antibody & Protein Engineering
T Cell Engagement and Redirection – Strategies, Methods, and T Cell Design
Oxford Global’s Discussion Groups provide a focused networking opportunity for a handful of like-minded experts on a monthly basis. Our February Discussion Group addressing ‘T Cell Engagement and Redirection – Strategies, Methods, and T Cell Design’ was a tremendous success. The discussion brought together an exclusive panel of key opinion leaders to address the key factors behind the market’s growth, its priorities, future outlook, and challenges.
Oligo Chemistry
Optimising Oligonucleotide Therapies: Efficacy, Targetability, and Precision Medicine
With efficacy, safety, and targetability being the top three challenges facing the nucleotide-based therapeutic industry today, will oligo-based therapies fulfil their potential as a clinical modality?
Oligo Chemistry
Oligonucleotide Chemistry & Therapeutics Symposium: Market Trends and Industry Challenges
The first of its kind, the Oligonucleotides: Chemistry & Therapeutics Symposium was a hit. We sat down with an advisory group of leading industry experts to hear their thoughts on the future of the Oligonucleotide drug industry as well as some of its key market trends and challenges.
Oligo Chemistry
Characterisation of Therapeutic Oligonucleotides in Early Drug Discovery
Oligonucleotides are fast becoming a globally recognised form of therapeutic treatment. But how easy is it to analyse them? Director of AstraZeneca, Tomas Leek takes us through the analytic challenges of the early-stage oligonucleotide characterisation.
Immuno-Oncology
Multi-Specific Protein Modalities For Solid Tumours
An interview with Rajika Perera, Chief Executive Officer, Poseidon Laboratory
Cell Line Development
Cell Line Development with Advanced Cell Line Engineering
The need to demonstrate clonality for regulatory approval means that now more than ever, the industry must look towards streamlining and optimising clone selection efficacy. We sat down with senior representatives from Ichnos Sciences and Sanofi to learn how.
NextGen Therapeutics
Harnessing Bispecific T Cell Engagers and T Cell Primers in Cancer Treatment
Stimulating T cells using bispecific antibody immunotherapies can lead to transformational clinical benefits for cancer patients. So how exactly is the industry addressing the need for targeted T cell-based immunotherapies?